274 related articles for article (PubMed ID: 24112192)
1. Anticholinergic drug burden in older people's brain - how well is it measured?
Kersten H; Wyller TB
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):151-9. PubMed ID: 24112192
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
BMC Geriatr; 2015 Mar; 15():31. PubMed ID: 25879993
[TBL] [Abstract][Full Text] [Related]
3. [The adverse effects of anticholinergic drugs].
Iwaki H; Nomoto M
Brain Nerve; 2014 May; 66(5):551-60. PubMed ID: 24807371
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
[TBL] [Abstract][Full Text] [Related]
5. Drugs with anticholinergic properties: a current perspective on use and safety.
Gerretsen P; Pollock BG
Expert Opin Drug Saf; 2011 Sep; 10(5):751-65. PubMed ID: 21635190
[TBL] [Abstract][Full Text] [Related]
6. Expert-based drug lists to measure anticholinergic burden: similar names, different results.
Lertxundi U; Domingo-Echaburu S; Hernandez R; Peral J; Medrano J
Psychogeriatrics; 2013 Mar; 13(1):17-24. PubMed ID: 23551407
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic Review.
Stewart C; Yrjana K; Kishor M; Soiza RL; Taylor-Rowan M; Quinn TJ; Loke YK; Myint PK
J Am Med Dir Assoc; 2021 Jan; 22(1):56-64. PubMed ID: 32709405
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergics: theoretical and clinical overview.
Nishtala PS; Salahudeen MS; Hilmer SN
Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
[TBL] [Abstract][Full Text] [Related]
9. A drug burden index to define the functional burden of medications in older people.
Hilmer SN; Mager DE; Simonsick EM; Cao Y; Ling SM; Windham BG; Harris TB; Hanlon JT; Rubin SM; Shorr RI; Bauer DC; Abernethy DR
Arch Intern Med; 2007 Apr; 167(8):781-7. PubMed ID: 17452540
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.
Salahudeen MS; Hilmer SN; Nishtala PS
J Am Geriatr Soc; 2015 Jan; 63(1):85-90. PubMed ID: 25597560
[TBL] [Abstract][Full Text] [Related]
11. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic burden: clinical implications for seniors and strategies for clinicians.
Karimi S; Dharia SP; Flora DS; Slattum PW
Consult Pharm; 2012 Aug; 27(8):564-82. PubMed ID: 22910177
[TBL] [Abstract][Full Text] [Related]
13. Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures.
Pont LG; Nielen JT; McLachlan AJ; Gnjidic D; Chan L; Cumming RG; Taxis K
Br J Clin Pharmacol; 2015 Nov; 80(5):1169-75. PubMed ID: 25923961
[TBL] [Abstract][Full Text] [Related]
14. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
15. Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes.
Lavrador M; Castel-Branco MM; Cabral AC; Veríssimo MT; Figueiredo IV; Fernandez-Llimos F
Pharmacol Res; 2021 Jan; 163():105306. PubMed ID: 33248197
[TBL] [Abstract][Full Text] [Related]
16. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
[TBL] [Abstract][Full Text] [Related]
17. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.
Lisibach A; Benelli V; Ceppi MG; Waldner-Knogler K; Csajka C; Lutters M
Eur J Clin Pharmacol; 2021 Feb; 77(2):147-162. PubMed ID: 33011824
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
[TBL] [Abstract][Full Text] [Related]
19. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients.
Lavrador M; Cabral AC; Figueiredo IV; Veríssimo MT; Castel-Branco MM; Fernandez-Llimos F
Int J Clin Pharm; 2021 Feb; 43(1):128-136. PubMed ID: 32860598
[TBL] [Abstract][Full Text] [Related]
20. Systematic review on the use of anticholinergic scales in poly pathological patients.
Villalba-Moreno AM; Alfaro-Lara ER; Pérez-Guerrero MC; Nieto-Martín MD; Santos-Ramos B
Arch Gerontol Geriatr; 2016; 62():1-8. PubMed ID: 26518612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
